151 related articles for article (PubMed ID: 29174945)
1. Preoperative predictors of nonorgan-confined disease in upper-tract urothelial carcinoma differ between China and the United States.
Singla N; Fang D; Su X; Bao Z; Cao Z; Robyak H; Xiong G; Zhang L; Woldu S; Hutchinson R; Sagalowsky A; Lotan Y; Li X; Zhou L; Raman JD; Margulis V
Urol Oncol; 2018 Mar; 36(3):88.e11-88.e18. PubMed ID: 29174945
[TBL] [Abstract][Full Text] [Related]
2. Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma.
Favaretto RL; Shariat SF; Savage C; Godoy G; Chade DC; Kaag M; Bochner BH; Coleman J; Dalbagni G
BJU Int; 2012 Jan; 109(1):77-82. PubMed ID: 21631698
[TBL] [Abstract][Full Text] [Related]
3. Preoperative multiplex nomogram for prediction of high-risk nonorgan-confined upper-tract urothelial carcinoma.
Petros FG; Qiao W; Singla N; Clinton TN; Robyak H; Raman JD; Margulis V; Matin SF
Urol Oncol; 2019 Apr; 37(4):292.e1-292.e9. PubMed ID: 30584035
[TBL] [Abstract][Full Text] [Related]
4. Preoperative predictive model and nomogram for disease recurrence following radical nephroureterectomy for high grade upper tract urothelial carcinoma.
Freifeld Y; Ghandour R; Singla N; Woldu S; Clinton T; Kulangara R; Bagrodia A; Matin SF; Petros FG; Raman JD; Robyak H; Yan J; Zhu H; Rapoport L; Lotan Y; Margulis V
Urol Oncol; 2019 Oct; 37(10):758-764. PubMed ID: 31378586
[TBL] [Abstract][Full Text] [Related]
5. Development of a Preoperative Nomogram Incorporating Biomarkers of Systemic Inflammatory Response to Predict Nonorgan-confined Urothelial Carcinoma of the Bladder at Radical Cystectomy.
Lucca I; Hofbauer SL; Leitner CV; de Martino M; Özsoy M; Susani M; Shariat SF; Klatte T
Urology; 2016 Sep; 95():132-8. PubMed ID: 27316373
[TBL] [Abstract][Full Text] [Related]
6. The preoperative serum cystatin-C as an independent prognostic factor for survival in upper tract urothelial carcinoma.
Tan P; Shi M; Chen J; Xu H; Xie N; Xu H; Jiang Y; Ai JZ; Liu LR; Yang L; Wei Q
Asian J Androl; 2019; 21(2):163-169. PubMed ID: 30416134
[TBL] [Abstract][Full Text] [Related]
7. Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma.
Brien JC; Shariat SF; Herman MP; Ng CK; Scherr DS; Scoll B; Uzzo RG; Wille M; Eggener SE; Terrell JD; Lucas SM; Lotan Y; Boorjian SA; Raman JD
J Urol; 2010 Jul; 184(1):69-73. PubMed ID: 20478585
[TBL] [Abstract][Full Text] [Related]
8. Risk stratification model, including preoperative serum C-reactive protein and estimated glomerular filtration rate levels, in patients with upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy.
Morizane S; Yumioka T; Yamaguchi N; Masago T; Honda M; Sejima T; Takenaka A
Int Urol Nephrol; 2015 Aug; 47(8):1335-41. PubMed ID: 26104379
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment elevated fibrinogen level predicts worse oncologic outcomes in upper tract urothelial carcinoma.
Xu H; Ai JZ; Tan P; Lin TH; Jin X; Gong LN; Lei HR; Yang L; Wei Q
Asian J Androl; 2020; 22(2):177-183. PubMed ID: 31169138
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of preoperative renal function and gross hematuria for intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma.
Hashimoto T; Nakashima J; Kashima T; Hirasawa Y; Shimodaira K; Gondo T; Nakagami Y; Namiki K; Horiguchi Y; Ohno Y; Ohori M; Tachibana M
Int J Urol; 2017 Feb; 24(2):111-116. PubMed ID: 27875859
[TBL] [Abstract][Full Text] [Related]
11. Preoperative Plasma Fibrinogen Level Represents an Independent Prognostic Factor in a Chinese Cohort of Patients with Upper Tract Urothelial Carcinoma.
Zhang B; Song Y; Jin J; Zhou LQ; He ZS; Shen C; He Q; Li J; Liu LB; Wang C; Chen XY; Fan Y; Hu S; Zhang L; Yu W; Han WK
PLoS One; 2016; 11(3):e0150193. PubMed ID: 26930207
[TBL] [Abstract][Full Text] [Related]
12. Predictive and Prognostic Value of Preoperative Thrombocytosis in Upper Tract Urothelial Carcinoma.
Foerster B; Moschini M; Abufaraj M; Soria F; Gust KM; Rouprêt M; Karakiewicz PI; Briganti A; Rink M; Kluth L; Mathieu R; Margulis V; Lotan Y; Aziz A; John H; Shariat SF;
Clin Genitourin Cancer; 2017 Dec; 15(6):e1039-e1045. PubMed ID: 28694147
[TBL] [Abstract][Full Text] [Related]
13. Tumour architecture, grade and location remain predictors of non-organ-confined upper tract urothelial carcinoma at time of radical nephroureterectomy: results from a multicenter Norwegian external validation study.
Almås B; Øverby S; Halvorsen OJ; Reisæter LAR; Assmus J; Carlsen B; Loe A; Beisland C
World J Urol; 2020 Mar; 38(3):717-723. PubMed ID: 31123851
[TBL] [Abstract][Full Text] [Related]
14. Caveolin-1 Expression in Upper Tract Urothelial Carcinoma.
D'Andrea D; Moschini M; Foerster B; Abufaraj M; Margulis V; Karam J; Lotan Y; Raman J; Mathieu R; Rouprêt M; Karakiewicz PI; Briganti A; Haitel A; Shariat SF
Eur Urol Focus; 2019 Jan; 5(1):97-103. PubMed ID: 28753840
[TBL] [Abstract][Full Text] [Related]
15. Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review.
Cutress ML; Stewart GD; Zakikhani P; Phipps S; Thomas BG; Tolley DA
BJU Int; 2012 Sep; 110(5):614-28. PubMed ID: 22471401
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Role of Neutrophil-to-lymphocyte Ratio-based Markers During Pre- and Postadjuvant Chemotherapy in Patients With Advanced Urothelial Carcinoma of Upper Urinary Tract.
Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
Clin Genitourin Cancer; 2017 Aug; 15(4):e633-e643. PubMed ID: 28174011
[TBL] [Abstract][Full Text] [Related]
17. A Multi-Institutional Comparison of Clinicopathological Characteristics and Oncologic Outcomes of Upper Tract Urothelial Carcinoma in China and the United States.
Singla N; Fang D; Su X; Bao Z; Cao Z; Jafri SM; Xiong G; Zhang L; Hutchinson R; Sagalowsky A; Lotan Y; Li X; Zhou L; Raman JD; Margulis V
J Urol; 2017 May; 197(5):1208-1213. PubMed ID: 27887951
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
[TBL] [Abstract][Full Text] [Related]
19. Development and external validation of a novel nomogram to predict intravesical recurrence after radical nephroureterectomy: a multicenter study.
Luo Z; Jiao B; Huang T; Zhao H; He W; Bo Y; Ding Z; Zhang G
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11223-11231. PubMed ID: 37355502
[TBL] [Abstract][Full Text] [Related]
20. Novel Use of Circulating Tumor DNA to Identify Muscle-invasive and Non-organ-confined Upper Tract Urothelial Carcinoma.
Huelster HL; Gould B; Schiftan EA; Camperlengo L; Davaro F; Rose KM; Soupir AC; Jia S; Zheng T; Sexton WJ; Pow-Sang J; Spiess PE; Daniel Grass G; Wang L; Wang X; Vosoughi A; Necchi A; Meeks JJ; Faltas BM; Du P; Li R
Eur Urol; 2024 Mar; 85(3):283-292. PubMed ID: 37802683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
